Approval · Notice of Compliance 565 · 2002
OPTIMARK: Notice of Compliance 565
Issued May 27, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 565
- Date
- May 27, 2002
- Company
- Tyco HealthcarePointe-Claire, Quebec, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Paramagnetic, intravascular contrast agent for magnetic resonance imaging (mri)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OPTIMARK | 02242986 | Cancelled Post Market |
Medicinal ingredients
- GADOVERSETAMIDE 330.9 MG per ML